RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pharmaron Beijing Co Stock

Pharmaron Beijing Co Liabilities 2024

Pharmaron Beijing Co Liabilities

13.92 B CNY

Ticker

300759.SZ

ISIN

CNE100003JW4

In 2024, Pharmaron Beijing Co's total liabilities amounted to 13.92 B CNY, a 39.98% difference from the 9.94 B CNY total liabilities in the previous year.

Pharmaron Beijing Co Aktienanalyse

What does Pharmaron Beijing Co do?

Pharmaron Beijing Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Pharmaron Beijing Co's Liabilities

Pharmaron Beijing Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Pharmaron Beijing Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Pharmaron Beijing Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Pharmaron Beijing Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Pharmaron Beijing Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Pharmaron Beijing Co stock

What is the level of liabilities of Pharmaron Beijing Co this year?

Pharmaron Beijing Co has a debt balance of 13.92 B CNY this year.

What were the liabilities of Pharmaron Beijing Co compared to the previous year?

The liabilities of Pharmaron Beijing Co have increased by 39.98% increased compared to the previous year.

What are the consequences of high debt for investors of Pharmaron Beijing Co?

High liabilities can pose a risk for investors of Pharmaron Beijing Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Pharmaron Beijing Co?

Low liabilities mean that Pharmaron Beijing Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Pharmaron Beijing Co affect the company?

An increase in liabilities of Pharmaron Beijing Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Pharmaron Beijing Co affect the company?

A decrease in the liabilities of Pharmaron Beijing Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Pharmaron Beijing Co?

Some factors that can influence the liabilities of Pharmaron Beijing Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Pharmaron Beijing Co so important for investors?

The liabilities of Pharmaron Beijing Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Pharmaron Beijing Co take to modify the liabilities?

To change its liabilities, Pharmaron Beijing Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Pharmaron Beijing Co pay?

Over the past 12 months, Pharmaron Beijing Co paid a dividend of 0.2 CNY . This corresponds to a dividend yield of about 0.72 %. For the coming 12 months, Pharmaron Beijing Co is expected to pay a dividend of 0.22 CNY.

What is the dividend yield of Pharmaron Beijing Co?

The current dividend yield of Pharmaron Beijing Co is 0.72 %.

When does Pharmaron Beijing Co pay dividends?

Pharmaron Beijing Co pays a quarterly dividend. This is distributed in the months of July, July, August, July.

How secure is the dividend of Pharmaron Beijing Co?

Pharmaron Beijing Co paid dividends every year for the past 8 years.

What is the dividend of Pharmaron Beijing Co?

For the upcoming 12 months, dividends amounting to 0.22 CNY are expected. This corresponds to a dividend yield of 0.79 %.

In which sector is Pharmaron Beijing Co located?

Pharmaron Beijing Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharmaron Beijing Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharmaron Beijing Co from 6/27/2024 amounting to 0.2 CNY, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Pharmaron Beijing Co pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Pharmaron Beijing Co in the year 2023?

In the year 2023, Pharmaron Beijing Co distributed 0.2 CNY as dividends.

In which currency does Pharmaron Beijing Co pay out the dividend?

The dividends of Pharmaron Beijing Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pharmaron Beijing Co

Our stock analysis for Pharmaron Beijing Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharmaron Beijing Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.